Aus­tralian man­u­fac­tur­er ac­quired by cap­i­tal in­vest­ment firm with ex­pe­ri­ence in CD­MO space

An Aus­tralian CD­MO is look­ing at a new name and new hori­zons as a cap­i­tal in­vest­ment firm has ac­quired it.

Luina Bio, based in Dar­ra, Aus­tralia, a sub­urb of Bris­bane, has been ac­quired by Am­per­sand Cap­i­tal Part­ners, a health-cen­tered pri­vate eq­ui­ty firm that has ex­pe­ri­ence in the CD­MO are­na, and by Glenn Haifer, a biotech in­vestor and chair­man of the board at Luina.

The ac­qui­si­tion, for which the fi­nan­cial de­tails were not giv­en to End­points News, will see the com­pa­ny re­brand and change its name to Acur­aBio. In an email to End­points, Am­per­sand Cap­i­tal stat­ed that it ac­quired the com­pa­ny be­cause of its po­ten­tial and sci­en­tif­ic ex­pe­ri­ence.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER